| Application number | Title of the application | Filing Date | Status |
|---|
| 09/642609 | Methods and compositions for reducing serum phosphate levels | Aug 16, 2000 | Abandoned |
| 09/636491 | Dipeptides for prevention of muscle breakdown and microbial infection | Aug 10, 2000 | Abandoned |
| 09/636149 | Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines | Aug 9, 2000 | Abandoned |
Array
(
[id] => 1059743
[patent_doc_number] => 06852833
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Artificial chaperon kit'
[patent_app_type] => utility
[patent_app_number] => 09/635429
[patent_app_country] => US
[patent_app_date] => 2000-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5233
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852833.pdf
[firstpage_image] =>[orig_patent_app_number] => 09635429
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/635429 | Artificial chaperon kit | Aug 9, 2000 | Issued |
Array
(
[id] => 1089346
[patent_doc_number] => 06828304
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-07
[patent_title] => 'Peptides for treatment of cancer'
[patent_app_type] => B1
[patent_app_number] => 09/630345
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3838
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/828/06828304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09630345
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/630345 | Peptides for treatment of cancer | Jul 30, 2000 | Issued |
Array
(
[id] => 1333127
[patent_doc_number] => 06596692
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Substance P analogs for the treatment of cancer'
[patent_app_type] => B1
[patent_app_number] => 09/629642
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6529
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596692.pdf
[firstpage_image] =>[orig_patent_app_number] => 09629642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/629642 | Substance P analogs for the treatment of cancer | Jul 30, 2000 | Issued |
Array
(
[id] => 1248392
[patent_doc_number] => 06673771
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Methods of inhibiting osteoclast activity'
[patent_app_type] => B1
[patent_app_number] => 09/628665
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13551
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09628665
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628665 | Methods of inhibiting osteoclast activity | Jul 27, 2000 | Issued |
Array
(
[id] => 1382885
[patent_doc_number] => 06555659
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w'
[patent_app_type] => B1
[patent_app_number] => 09/625043
[patent_app_country] => US
[patent_app_date] => 2000-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9607
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555659.pdf
[firstpage_image] =>[orig_patent_app_number] => 09625043
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625043 | Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w | Jul 23, 2000 | Issued |
| 09/619069 | Hyaluronic acid-protein conjugates, pharmaceutical compositions and related methods | Jul 18, 2000 | Abandoned |
Array
(
[id] => 1582233
[patent_doc_number] => 06423830
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-23
[patent_title] => 'Process for purifying apolipoprotein A or apolipoprotein E'
[patent_app_type] => B1
[patent_app_number] => 09/617898
[patent_app_country] => US
[patent_app_date] => 2000-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8188
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/423/06423830.pdf
[firstpage_image] =>[orig_patent_app_number] => 09617898
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/617898 | Process for purifying apolipoprotein A or apolipoprotein E | Jul 16, 2000 | Issued |
Array
(
[id] => 1545692
[patent_doc_number] => 06444641
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Fatty acid-acylated insulin analogs'
[patent_app_type] => B1
[patent_app_number] => 09/530038
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19110
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444641.pdf
[firstpage_image] =>[orig_patent_app_number] => 09530038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/530038 | Fatty acid-acylated insulin analogs | Jul 6, 2000 | Issued |
Array
(
[id] => 1327747
[patent_doc_number] => 06599881
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Antithrombotic materials and methods'
[patent_app_type] => B1
[patent_app_number] => 09/610785
[patent_app_country] => US
[patent_app_date] => 2000-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16650
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599881.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610785
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610785 | Antithrombotic materials and methods | Jul 5, 2000 | Issued |
| 09/603713 | Inhibitors of memapsin 2 and use thereof | Jun 26, 2000 | Abandoned |
| 09/603338 | Novel indazole peptidomimetics as thrombin receptor antagonist | Jun 25, 2000 | Abandoned |
Array
(
[id] => 1368848
[patent_doc_number] => 06566329
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Freeze-dried preparation of human growth hormone'
[patent_app_type] => B1
[patent_app_number] => 09/594103
[patent_app_country] => US
[patent_app_date] => 2000-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2336
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566329.pdf
[firstpage_image] =>[orig_patent_app_number] => 09594103
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/594103 | Freeze-dried preparation of human growth hormone | Jun 13, 2000 | Issued |
Array
(
[id] => 1415804
[patent_doc_number] => 06521595
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Nonimmunosuppressive -hydroxy-methylleucine4 cyclosporin A, hair growth stimulator and external composition for skin using the same'
[patent_app_type] => B1
[patent_app_number] => 09/580694
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 23
[patent_no_of_words] => 5226
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521595.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580694
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580694 | Nonimmunosuppressive -hydroxy-methylleucine4 cyclosporin A, hair growth stimulator and external composition for skin using the same | May 29, 2000 | Issued |
Array
(
[id] => 1034530
[patent_doc_number] => 06875740
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens'
[patent_app_type] => utility
[patent_app_number] => 09/926679
[patent_app_country] => US
[patent_app_date] => 2000-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2758
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875740.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926679 | Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens | May 23, 2000 | Issued |
Array
(
[id] => 1348123
[patent_doc_number] => 06579847
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Method and apparatus for vascular neuromuscular blockade'
[patent_app_type] => B1
[patent_app_number] => 09/563765
[patent_app_country] => US
[patent_app_date] => 2000-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 4667
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09563765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563765 | Method and apparatus for vascular neuromuscular blockade | Apr 30, 2000 | Issued |
Array
(
[id] => 1096289
[patent_doc_number] => 06821950
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors'
[patent_app_type] => B1
[patent_app_number] => 09/446109
[patent_app_country] => US
[patent_app_date] => 2000-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 11735
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821950.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446109 | Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors | Apr 20, 2000 | Issued |
Array
(
[id] => 750731
[patent_doc_number] => 07022822
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-04
[patent_title] => 'Highly purified gonadotropin compositions and process for preparing them'
[patent_app_type] => utility
[patent_app_number] => 09/958802
[patent_app_country] => US
[patent_app_date] => 2000-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8870
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022822.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958802 | Highly purified gonadotropin compositions and process for preparing them | Apr 13, 2000 | Issued |
